Congratulations to Lars Pinborg for being granted DKK 103.100 from FSS for a scholarstipend for Sebastian Ebert and his project 'Neuroinflammations betydning ved commotio cerebri og post-commotionelt syndrom', and to Gitte Moos Knudsen for receiving DKK 100.000 from Ester M og Konrad Kristian Sigurdssons Dyreværnsfond for the NeuroPharm project 'Neurobiologiske effekter af serotonin 2A receptor modulering – en ny måde at vurdere lægemidler vha. moderne hjernescanningsmetoder'.
Congratulations to Mette Thrane Foged for receiving DKK 32.000 from Lennart Grams Mindefond for her project 'Pre-surgical identification of epileptic foci measured with EEG and HD EEG' and to Vincent Beliveau who has received DKK 15.000 from the University of Copenhagen for his six weeks stay at Stephen Strother's laboratory at the Rotman Research Institute in Toronto.
Prof. Jens Damsgaard Mikkelsen has received 435,000 DKK from The Lundbeck Foundation for the project "ASEM as a novel high-affinity radioligand for imaging alpha7 nicotinic acetylcholine receptors: Applicability for imaging with in vitro autoradiography and positron emission tomography (PET)".
Tuesday Oct 11th, "TV2 Nyhederne" ran a story about the Aggression study that has recently been conducted at NRU as part of Sofi da Cunha-Bang's PhD project. Gitte Moos Knudsen was interviewed as part of the story.
Congratulations to PhD student Mette Thrane Foged from NRU for recently winning a poster award at the "12th European Congress on Epileptology" which was held on September 11th-15th in Prague, Czech Republic.
On Friday September 23rd, NRU will be celebrating 20 years anniversary as independent research unit. The celebration will start at 2pm in Auditorium 2 at Rigshospitalet where there will be a 3-hour symposium with talks (in Danish) by current and previous NRU employees. The program for the symposium can be found below.
Gitte Moos Knudsen has recently received a grant worth 1.844 mio DKK from the The Danish Council for Independent Research - Medical Sciences for the project "In vivo assessment of novel pharmacological interventions in humans: An experimental medicine approach evaluating psilocybin and the serotonin 2A receptor". The project has a direct link to WP2 in NeuroPharm.